2-(4-溴苯基)-丙二酸-1,3-二乙酯合成路线 (共 6 条)
反应条件
1: ethyl (4-bromophenyl)ethanoate With lithium diisopropyl amide in tetrahydrofuran T=-78°C; 1 h; 2: [(Cyanocarbonyl)oxy]ethane in tetrahydrofuran T=-78 - 20°C;
参考文献
Katz, Christopher E.; Aube, Jeffrey
Journal of the American Chemical Society, 2003 , vol. 125, # 46 p. 13948 - 13949
反应条件
1: diethyl malonate With N,N,N',N',N'',N''-hexamethylphosphoric triamide; sodium hydride in 1,4-dioxane; mineral oil T=20°C; 1 h; Inert atmosphere; 2: 4-bromo-1-iodobenzene With copper(I) bromide in 1,4-dioxane; mineral oil 5 h; Reflux;
参考文献
MITSUBISHI TANABE PHARMA CORPORATION; SANOFI-AVENTIS; WATANABE, Kazutoshi; NAKAYAMA, Kazuki; SAKAI, Daiki
Patent: WO2010/114179 A1, 2010 ;
Location in patent: Page/Page column 37 ;
WO 2010/114179 A1
反应条件
1.1: 94 percent / conc. HCl / Heating 2.1: LHMDS / tetrahydrofuran; hexane / -78 °C 2.2: 66 percent / tetrahydrofuran; hexane / -78 - 20 °C View Scheme
参考文献
Bioorganic and Medicinal Chemistry, , vol. 15, # 4 p. 1586 - 1605
反应条件
1: sodium hydride / tetrahydrofuran
2: lithium aluminum hydride / tetrahydrofuran; water
View Scheme
参考文献
Vertex Pharmaceuticals Incorported
Patent: US2011/98311 A1, 2011 ;
反应条件
1: sodium hydride / tetrahydrofuran
2: lithium aluminum hydride / tetrahydrofuran; water
3: diisopropyl (E)-diazene-1,2-dicarboxylate / toluene
View Scheme
参考文献
Vertex Pharmaceuticals Incorported
Patent: US2011/98311 A1, 2011 ;